---
provider: openai
model: o3-deep-research-2025-06-26
cached: true
start_time: '2025-11-03T23:06:26.382527'
end_time: '2025-11-03T23:06:26.384012'
duration_seconds: 0.0
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: Q05084
  gene_symbol: ICA1
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    temperature: 0.1
    top_p: 1.0
citation_count: 92
---

## Question

# Gene Research for Functional Annotation

Please provide a comprehensive research report on the gene ICA1 (Q05084) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function. 

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

# Introduction  
**ICA1** (Islet Cell Autoantigen 1), also known as **ICA69**, is a human gene encoding a protein of approximately 483 amino acids that was first identified as an autoantigen in type 1 diabetes ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69)). The ICA1 protein contains an **arfaptin homology domain**, indicating structural similarity to arfaptin proteins ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200)). This domain is a type of BAR (Bin/Amphiphysin/Rvs) domain known for binding lipid membranes and sensing or inducing membrane curvature ([www.bioch.ox.ac.uk](https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and)). ICA1 is predominantly a cytosolic protein that can associate peripherally with intracellular membranes, especially the **Golgi complex** and **immature secretory granules** ([www.wikidoc.org](https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1)). It is broadly expressed in pancreatic islet β-cells and other neuroendocrine tissues ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L528%20Ica1%2C%20is,ICA69%20is)), consistent with its initial discovery as a target of autoimmune responses in endocrine disorders. While ICA1’s name and historical interest stem from autoimmunity, modern research has illuminated its fundamental role in vesicle formation and intracellular trafficking processes, rather than any enzymatic or transport activity. Below, we detail ICA1’s molecular function, the biological pathways it participates in, its subcellular localization, and the evidence linking ICA1 to specific cellular roles and diseases, with an emphasis on recent findings (2023–2024) from the scientific literature.

# Structural Features and Localization  
The ICA1 gene product is a **BAR domain-containing protein** approximately 69 kDa in size (483 amino acids) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69)). BAR domains are crescent-shaped dimerization modules that bind to curved membranes; accordingly, ICA1 often functions as a dimer or heterodimer that can **“bend the lipid membrane”** to shape vesicular structures ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or)). Notably, ICA1’s BAR domain is in its N-terminal half and is highly similar to that of arfaptins ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200)), a family of proteins known to interact with Arf GTPases and membrane surfaces. This domain architecture enables ICA1 to exist in both soluble and membrane-bound states. Indeed, ICA1 is found **diffusely in the cytosol** as well as **attached to membranes of the Golgi apparatus and secretory vesicles** ([www.wikidoc.org](https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1)). Early cell biology studies localized ICA1 to the Golgi complex in insulin-secreting cells ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200)), and it is particularly enriched on the **trans-Golgi network (TGN)** and on **immature secretory granule membranes** in pancreatic β-cells ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69)). These observations suggest that ICA1 dynamically shuttles between the cytosol and membranes during vesicle biogenesis. ICA1 lacks any known enzymatic active site or transmembrane region; instead, its primary structure is adapted for **protein–protein and protein–lipid interactions** that facilitate vesicle formation. The protein can form complexes with itself or other BAR domain proteins, and it has an affinity for curved phospholipid membranes ([www.bioch.ox.ac.uk](https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and)). This structural context underlies ICA1’s role as a scaffolding or adaptor protein in membrane trafficking rather than as a catalyst.  

In terms of cellular distribution, ICA1 is **predominantly expressed in secretory and neuroendocrine cells**. For example, in humans and rodents it is highly expressed in pancreatic islets (insulin-producing β-cells) and in brain regions with dense synaptic activity ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L528%20Ica1%2C%20is,ICA69%20is)). Its **conservation across species** highlights its fundamental role: the Caenorhabditis elegans homolog of ICA1 (RIC-19) is required for neurotransmitter secretion in worms ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Islet,are%20conserved%20regulators%20of%20neuroendocrine)). This evolutionary conservation – from worm neurons to human β-cells – underscores ICA1’s core function in vesicle dynamics across the neuroendocrine system. At the subcellular level, ICA1 has been observed at sites of vesicle budding and maturation. Specifically, immunolocalization experiments in pancreatic cells showed ICA1 on the cytosolic face of immature insulin granules budding from the TGN ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water)). Treatment of cells with brefeldin A (which blocks ER-to-Golgi and TGN export) causes ICA1 to accumulate at the TGN ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=different%20stages%20of%20their%20maturation,to%20increased%20food%20and%20water)), consistent with ICA1 cycling on/off membranes during vesicle biogenesis. In summary, ICA1 is a **cytosolic adaptor** that localizes to the **Golgi and secretory vesicle membranes**, positioning it perfectly to mediate the formation and trafficking of secretory vesicles.

# Role in Secretory Vesicle Formation and Trafficking  
One of the primary functions of ICA1 is the regulation of **secretory vesicle biogenesis in endocrine cells**. This role has been elucidated through both cell-based experiments and animal models. ICA1 acts as a **critical scaffolding protein in the early secretory pathway**, ensuring that hormone and neurotransmitter cargo are properly packaged into dense-core secretory granules. A landmark study in 2008 by Buffa et al. showed that ICA1 directly interacts with the small GTPase **Rab2** and regulates trafficking between the endoplasmic reticulum (ER) and Golgi ([www.bioch.ox.ac.uk](https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and)) ([www.bioch.ox.ac.uk](https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in)). Rab2 is known to control the transport of COPI-coated vesicles between the ER and Golgi. ICA1 was identified as a **Rab2 effector** that is recruited to Golgi membranes when Rab2 is in its active GTP-bound state ([www.bioch.ox.ac.uk](https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in)). Mechanistically, Rab2 binding targets ICA1 to sites of vesicle budding, where ICA1’s BAR domain can bind and deform membranes. Perturbing the levels of either Rab2 or ICA1 has significant consequences: Buffa and colleagues reported that **overexpression of ICA1 (or Rab2) in insulinoma cells slowed anterograde trafficking of secretory granule proteins and reduced insulin secretion** ([www.bioch.ox.ac.uk](https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in)). This dominant-negative effect suggests that precise amounts of ICA1 are needed for normal vesicle budding – too much ICA1 or Rab2 may “stall” or improperly curve the budding vesicles, highlighting ICA1’s role as a controller of vesicle formation kinetics. Consistently, depletion or loss of ICA1 also disrupts vesicle trafficking. In mice genetically engineered to lack ICA1, pancreatic β-cells exhibit defects in insulin storage and release (discussed further below) ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules)). Together, these findings position ICA1 as a **key regulatory factor in the early secretory pathway**, bridging the action of a GTPase (Rab2) with the physical process of vesicle budding at the ER–Golgi and Golgi–granule interface.

Beyond the ER–Golgi step, ICA1 is especially important at the level of **immature secretory granule formation from the TGN**. ICA1 commonly works in concert with another BAR domain protein called **PICK1** (Protein Interacting with C Kinase 1). PICK1 and ICA1 form **heterodimers** that associate with secretory granules at specific stages of their maturation ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water)). Both proteins are banana-shaped BAR adapters that can sense membrane curvature. A 2013 study by Cao et al. (published in *PLOS Biology*) demonstrated that **PICK1–ICA1 heteromeric complexes bind to immature insulin granules budding from the TGN**, whereas mature granules retain PICK1 but lose ICA1 ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water)) ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules)). This suggests that ICA1’s role is most critical during the **“birth” of new secretory granules** – once the granule matures, ICA1 dissociates, and other factors (with PICK1 remaining) take over. Notably, treating cells with brefeldin A (to block new vesicle formation) led to an accumulation of both PICK1 and ICA1 at the TGN membrane ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=different%20stages%20of%20their%20maturation,to%20increased%20food%20and%20water)), reinforcing that **both proteins normally cycle on budding granules** and that ICA1 in particular is recruited during the vesicle formation stage. The functional importance of ICA1 in this process was proven by genetic loss-of-function: **mice lacking ICA1 exhibit impaired insulin granule maturation and secretion** ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules)). ICA1 knockout mice have elevated blood glucose levels and increased proinsulin-to-insulin ratios in their pancreatic islets ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules)). In other words, without ICA1, insulin is not effectively packaged and processed in granules – proinsulin (the precursor) accumulates and less mature insulin is available for release. Similarly, mice lacking PICK1 display almost identical phenotypes, including glucose intolerance and defective insulin processing ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules)). Importantly, PICK1-deficient mice also show a **complete loss of ICA1 protein in their islet β-cells** ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=in%20mice%20caused%20the%20complete,and%20maturation%20of%20insulin%20granules)). This indicates that ICA1’s stability or localization in cells depends on PICK1, and it suggests the two proteins function as a unit. The reverse may also be true: when ICA1 is absent, PICK1’s function in vesicle biogenesis is compromised. Indeed, these two BAR domain proteins have been dubbed “a pair of crescent-shaped proteins that shape vesicles at the Golgi” in commentary on the 2013 findings ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=Comment%20in%20,PICK1)). In summary, **ICA1’s primary function is to facilitate the budding of dense-core secretory granules**, working together with PICK1 to mold membranes at the TGN so that hormones (like insulin, as well as other peptide hormones) are properly packaged for secretion ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or)). Without ICA1, secretory vesicles are abnormally formed, leading to hormone retention as precursor forms and insufficient release into the bloodstream ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or)).

Beyond insulin, ICA1’s role in vesicle formation extends to other endocrine systems. The PICK1–ICA1 complex has been implicated in the biogenesis of **growth hormone (GH) secretory vesicles** in the pituitary gland as well. Holst et al. (2013) found that in both **Drosophila** and mice, these two proteins cooperate to bud off GH-containing granules, and loss of PICK1 leads to GH insufficiency and stunted growth ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR)). This generalizes the concept that ICA1 is not exclusive to insulin trafficking; it appears to be a *universal regulator of dense-core vesicles* in multiple cell types. In line with this, the earlier-mentioned C. elegans homolog RIC-19 works with the worm Rab2 (UNC-108) to ensure proper maturation of dense-core vesicles in neurons ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/22654674/#:~:text=Caenorhabditis%20elegans%20,specific%20cargo%20is%20lost%20from)). Worms lacking RIC-19 or Rab2 show loss of specific neuropeptide cargo from vesicles, underscoring a conserved function in cargo packaging ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/22654674/#:~:text=Caenorhabditis%20elegans%20,specific%20cargo%20is%20lost%20from)). Taken together, a broad picture emerges: **ICA1 is a scaffold that links membrane curvature to vesicle content sorting, ensuring that secretory vesicles form correctly and carry the proper cargo**. It acts at the crossroads of small GTPase signaling (Rab2 and possibly others) and the biophysical sculpting of the vesicle membrane (via BAR domain interactions). This positions ICA1 as an essential component of the **secretory pathway**, particularly for the biogenesis and maturation of **dense-core secretory granules** that store hormones and neuropeptides.

# Interaction with PICK1 and Neuronal Functions  
A major interacting partner of ICA1 is **PICK1**, and their partnership has functional consequences not only in endocrine cells but also in the nervous system. PICK1 is a multi-functional scaffold protein that contains a PDZ domain (which binds specific membrane protein tails) and a BAR domain. The **ICA1–PICK1 heterodimer** leverages both proteins’ BAR domains to form a composite curvature-sensing module, while PICK1’s PDZ domain connects to cargo proteins. In neurons, one of PICK1’s well-known roles is regulating the trafficking of AMPA-type glutamate receptors (AMPARs) at synapses, via its PDZ interaction with AMPAR subunits (GluA2/3) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=in%20the%20biogenesis%20of%20secretory,and%20morphological%20analysis%20of%20CA1)). Emerging research indicates that ICA1 participates in this process, linking secretory vesicle trafficking to synaptic receptor modulation. Proteomic studies found ICA1 in complexes with AMPA receptor subunits in the brain, suggesting ICA1 is present at excitatory synapses through its binding to PICK1 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=in%20the%20biogenesis%20of%20secretory,and%20morphological%20analysis%20of%20CA1)). Shu-Ling Chiu and colleagues (2023) recently demonstrated that **ICA1 is required for certain forms of synaptic plasticity** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory)). Specifically, **mice lacking ICA1 have normal basal synaptic transmission but show a selective impairment in long-term potentiation (LTP)** in the hippocampus, a brain region critical for learning and memory ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=levels,dependent%20learning%20and)). LTP is a strengthening of synapses often associated with an activity-dependent increase in the number of AMPA receptors at the synaptic membrane. In ICA1 knockout mice, while baseline levels of AMPA receptors and basic synaptic currents were unchanged, activity-dependent insertion of AMPARs during LTP was defective ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory)). This led to deficiencies in hippocampus-dependent learning tasks, linking **ICA1-mediated trafficking to cognitive function** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory)). Notably, the **loss of ICA1 did not affect long-term depression (LTD)**, the process of AMPAR removal from synapses ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory)). This divergence is telling: PICK1 is heavily implicated in LTD (facilitating receptor endocytosis), whereas ICA1 appears to be more important for the opposite process – the delivery of receptors (or other proteins) during potentiation ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory)). In essence, **ICA1 supports the forward trafficking (secretory insertion) of neurotransmitter receptors**, complementing PICK1’s role in retrieval and endocytosis. 

Mechanistically, how does ICA1 influence synaptic AMPAR delivery? The 2023 study found that **ICA1 regulates the localization and stability of PICK1 in neurons** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic)). In ICA1 knockout neurons, PICK1’s distribution was altered and its protein levels in the hippocampus were reduced ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic)). This mirrors the finding in β-cells that PICK1 requires ICA1 for stability (recall that PICK1 KO led to loss of ICA1, and here ICA1 KO impacts PICK1 levels – illustrating a mutual dependence) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=in%20mice%20caused%20the%20complete,and%20maturation%20of%20insulin%20granules)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic)). By keeping PICK1 appropriately localized, ICA1 likely ensures that AMPA receptors are cycled through the secretory pathway correctly. One possibility is that ICA1–PICK1 complexes in neurons help shuttle newly synthesized AMPA receptors from the Golgi out to the synaptic membrane (the so-called **de novo secretory pathway** for AMPARs) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=Long,to%20the%20cell%20surface%2C%20or)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=trafficking%20pathways%20regulate%20the%20surface,plasticity%20and%20animal%20behavior%20by)). This pathway is less studied than receptor recycling, but evidence suggests it plays a role in delivering fresh receptors during sustained synaptic strengthening ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=synapse%20trapping%20and%20subsequent%20endocytosis%2C,plasticity%20and%20animal%20behavior%20by)). The absence of ICA1 could specifically impair this forward delivery route, thus limiting the receptors available for LTP, even though the recycling/endocytosis route (involving PICK1 alone) remains intact for LTD. Earlier work by Cao et al. (2007) had already hinted at ICA1’s involvement in neuronal receptor trafficking: they reported that **PICK1–ICA1 complexes regulate the synaptic targeting and surface expression of AMPA receptors** ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=19,View%20Article)). The new 2023 findings solidify that concept and tie it to functional plasticity changes and memory behavior.

In summary, **ICA1 in the brain functions as a secretory trafficking protein that partners with PICK1 to influence neurotransmitter receptor placement at synapses**. It is not a classical signaling molecule on its own (it does not catalyze signaling reactions or directly bind neurotransmitters), but by controlling the movement of receptor-containing vesicles, ICA1 has a significant impact on synaptic signaling. This role is conceptually similar to its function in endocrine cells: in both cases, ICA1 helps prepare and deliver vesicles loaded with important cargo (insulin in β-cells, AMPA receptors in neurons) to their proper destination (the cell surface) at the right time. Thus, **ICA1 serves a broader structural and adaptor role in cells – orchestrating vesicle budding and cargo delivery in both secretory endocrine pathways and neuronal synaptic pathways**.

# Signaling Pathways and Molecular Interactions  
Although ICA1 is primarily a structural adaptor in vesicle biogenesis, its actions intersect with various **signaling pathways** through the proteins it interacts with. One key pathway is linked to the **small GTPase Rab2**, as mentioned above. By acting as a Rab2 effector, ICA1 becomes part of the **ER-to-Golgi trafficking machinery** that is essential for maintaining the flow of secretory proteins ([www.bioch.ox.ac.uk](https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in)). This places ICA1 downstream of Rab2 activation; when Rab2 is active, it recruits ICA1, which in turn helps deform membranes and perhaps select cargo. There is also evidence that ICA1 may interface with **Arf GTPases** or coat proteins indirectly, due to its arfaptin-homology (arfaptins typically bind Arf family GTPases). Indeed, ICA1 was described as “arfaptin-related” and associated with the Golgi, hinting that it might share functional similarities with arfaptin-2 (also called PICK1 in some older literature, though PICK1 is a distinct gene) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200)). This suggests ICA1 could be part of a network of **GTPase-regulated adaptors** that coordinate membrane trafficking events (Rab2 at the ERGIC/Golgi, possibly Arfs at the TGN). 

Another interaction of signaling relevance is with **protein kinase C (PKC)** pathways via PICK1. PICK1 was originally identified as a PKC-binding protein (hence “protein interacting with C-kinase”), and it can tether PKCα in neurons. Recent studies have uncovered a link between ICA1, PICK1, and PKCα signaling that has implications for Alzheimer’s disease (AD) pathology. In 2024, Ji et al. reported that **ICA1 expression is decreased in the brains of Alzheimer’s patients and model mice**, and that modulating ICA1 levels affects the processing of the Amyloid Precursor Protein (APP) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Islet%20cell%20autoantigen%201%20,and%20an%20AD%20mouse%20model)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD)). In cellular models, **overexpression of ICA1 shifted APP processing away from the amyloidogenic pathway toward the non-amyloidogenic pathway** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Conclusion)). Specifically, ICA1 increased the levels of the alpha-secretases ADAM10 and ADAM17 (which cut APP in a way that prevents toxic amyloid-β formation) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation)). It did not change APP gene expression or protein stability, but instead seemed to influence cell signaling such that more ADAM10/17 activity was directed at APP ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation)). Transcriptomic analysis in that study suggested ICA1 regulates G-protein coupled receptor signaling networks, and notably **ICA1 overexpression enhanced the abundance and phosphorylation of PKCα** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=17%20,PKC%CE%B1%20protein%20levels%20and%20phosphorylation)). PKCα activation is known to stimulate ADAM17 and non-amyloidogenic APP cleavage, so this finding connects the dots: **ICA1 might promote PKCα signaling via its interaction with PICK1**, since PICK1 can bind and cluster PKCα. By stabilizing PICK1 (as seen in neurons) or positioning a PKC–PICK1 complex at membranes, ICA1 could facilitate PKCα activation of ADAM10/17, thus biasing APP processing towards a pathway less likely to produce amyloidogenic peptides. The authors concluded that **ICA1 “shifts APP processing to non-amyloid pathways” by regulating the PICK1–PKCα axis**, and they proposed ICA1 as a potential therapeutic target for AD ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD)). This is a striking example of how a vesicle trafficking protein can influence a signaling cascade with disease relevance. It suggests that **ICA1’s role in trafficking extends into modulation of signaling enzymes** (like PKCα) by controlling their localization or assembly with substrates. While this connection is still being unraveled, it highlights that ICA1 is embedded in a web of **cellular pathways**: it interacts with small GTPases (Rab2), scaffold proteins (PICK1), and potentially kinases (PKCα), thereby linking membrane trafficking to signal transduction outcomes. 

It’s worth noting that ICA1 itself is not known to have direct catalytic activity or to function as a classical signaling receptor or ligand. Instead, its contribution to pathways is through **adaptor functions** – it brings together molecules (for example, helping PICK1 to cluster with PKCα, or enabling Rab2 to effect membrane changes). Through these interactions, ICA1 can influence **insulin signaling indirectly** (by controlling insulin secretion), **synaptic signaling** (by controlling neurotransmitter receptor availability), and even **cellular stress or growth signals** (given that dense-core vesicles also carry neuropeptides and hormones like growth hormone). In the pituitary and pancreatic context, for instance, proper vesicle maturation under ICA1’s guidance ensures that hormonal signals (insulin, growth hormone) are released appropriately in response to physiological cues ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR)). If ICA1 is dysfunctional, those signaling pathways (glucose homeostasis, growth regulation) suffer downstream effects (e.g., diabetes-like phenotypes or growth defects) ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR)). Thus, while ICA1 is not a **signaling enzyme**, it is intimately connected to multiple signaling pathways through the vesicular cargo it helps manage and the protein complexes it forms.

# Clinical and Biomedical Significance  
**Autoantigen in Type 1 Diabetes:** ICA1 was originally discovered in the context of autoimmune diabetes; autoantibodies against a 69 kDa islet cell protein (ICA69) were detected in patients with type 1 diabetes mellitus (T1D) and in some of their relatives years before disease onset ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells)). Subsequent research confirmed that both B-cell and T-cell responses against ICA1 can occur in T1D ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells)). However, compared to major islet autoantigens like insulin, GAD65, IA-2, and ZnT8, ICA69 autoantibodies are less prevalent and are not part of the standard clinical autoantibody panel for diabetes prediction ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=Anti,T1D%20and%20SPIDDM%20cases%20were)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=diabetes%20,islet)). They do appear in a subset of patients and even in other autoimmune disorders such as Sjögren’s syndrome and rheumatoid arthritis (in those diseases, the presence of ICA69 antibodies is thought to reflect immune cross-reactivity due to some shared antigenic epitopes or co-occurrence of autoimmune conditions) ([www.wikidoc.org](https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Seminal%20studies%20by%20Atkinson%20et,cell%20injury%20in)). The biological reason ICA1 breaks immune tolerance in some individuals is still being studied. Intriguingly, one hypothesis is that ICA1’s involvement in secretory granule biology links it to **β-cell stress**. During diabetogenesis, misfolded proteins or abnormal secretory granules in β-cells might lead to the release or abnormal presentation of ICA1 peptides, triggering autoimmunity ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=in%20the%20neuroendocrine%20system,In%20this%20context%2C%20we)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=autoantigens%20play%20diverse%20roles%20in,GAD65%2C%20ZnT8%2C%20IA2%2C%20and%20ICA69)). Another line of evidence comes from the role of the AIRE gene in thymic education: mouse studies have shown that lower expression of Ica1 in the thymus (due to certain polymorphisms) can result in incomplete deletion of ICA69-reactive T cells, predisposing to multi-organ autoimmunity ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L539%20autoreactive%20to,expression%20in%20medullary%20thymic%20epithelial)). Indeed, **mice lacking ICA1** (Ica1 knockout) are resistant to autoimmune diabetes in the NOD mouse model ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=match%20at%20L134%20while%20ICA69,accelerated%20diabetes%20%5B25)) – presumably because the immune system has no target to attack – yet these same mice suffer the consequences of impaired insulin secretion as described earlier. Thus, ICA1 sits at an interesting intersection of endocrinology and immunology: it is essential for normal β-cell function, but it can also become a victim of the immune system in T1D. This duality has prompted interest in ICA1 as a factor in diabetes pathogenesis, though targeting it for therapy is complex (completely removing ICA1 might blunt autoimmunity but at the cost of secretory function). Some researchers have suggested that measuring ICA69-specific T cells or antibodies could add information in understanding atypical or multi-autoimmune cases ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC4704797/#:~:text=For%20reasons%20not%20fully%20understood%2C,%CE%94ICA69%20line.%20Suboptimal%20central)), especially since ICA1 is also expressed in brain and other organs, possibly contributing to *other* autoimmune manifestations when central tolerance is compromised ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC4704797/#:~:text=For%20reasons%20not%20fully%20understood%2C,%CE%94ICA69%20line.%20Suboptimal%20central)).

**Neurodegeneration and Other Diseases:** Beyond autoimmunity, recent studies suggest ICA1 could be relevant in neurodegenerative and cognitive disorders. The 2024 study linking ICA1 to Alzheimer’s disease (AD) found that **brains of AD patients have significantly lower ICA1 levels compared to age-matched controls** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Islet%20cell%20autoantigen%201%20,and%20an%20AD%20mouse%20model)). While the causal direction is not established, the data showed that boosting ICA1 had protective biochemical effects: it upregulated non-amyloidogenic APP cleavage (increasing ADAM10/17 and soluble APPα production) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation)). Moreover, ICA1 overexpression in cellular models activated PKCα – a kinase known to be neuroprotective when it enhances α-secretase activity ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=17%20,PKC%CE%B1%20protein%20levels%20and%20phosphorylation)). These findings hint that ICA1 might normally support neuronal health by promoting beneficial signaling pathways (like PKC/α-secretase), and its decline in AD could remove this support, tilting APP processing toward the harmful amyloid-producing route. If further research confirms this mechanism, **ICA1 or its downstream effects could become therapeutic targets**. For instance, small molecules or biologics that stabilize the ICA1–PICK1 interaction or enhance ICA1 expression might foster a shift toward non-amyloidogenic APP processing, offering a novel strategy to reduce Aβ accumulation in AD ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD)). It is early to translate this into clinics, but it exemplifies how fundamental cell biology of a vesicle protein can unexpectedly point to disease-modifying approaches.

In neurological research, ICA1’s role in synaptic plasticity (as described earlier) also suggests relevance for cognitive disorders. The ICA1 knockout mice showed deficits in spatial learning ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory)), which raises the question of whether variations in the ICA1 gene or protein levels in humans could contribute to learning disabilities or memory impairment. So far, no specific human mutations in ICA1 have been definitively linked to neurological syndromes. However, given that ICA1 has a close paralog (ICA1L) and is part of a larger network, subtle perturbations might have been overlooked. Ongoing research in molecular neuroscience is likely to further explore ICA1’s role in brain functions and whether it could be a factor in disorders of synaptic dysfunction.

Finally, it’s worth noting that ICA1 has been examined in the context of **cancer** (because many proteins related to secretion can influence tumor cell secretory phenotypes) and other metabolic conditions. For example, some data exist on **insulinomas** (insulin-secreting pancreatic tumors) where ICA1 is highly expressed, as expected for β-cell origin, and occasionally its autoantigen status has been exploited for diagnostic imaging or immune-based therapies in experimental settings ([www.genecards.org](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ICA1#:~:text=GeneCards%20Summary%20for%20ICA1%20Gene)). However, such applications are still exploratory. 

# Conclusion  
**ICA1 (Q05084)** encodes a multi-functional adaptor protein that plays a crucial role in the formation and function of secretory vesicles. In essence, ICA1 acts as a **molecular scaffold at the Golgi and on immature secretory granules**, using its BAR domain to mold membranes and partnering with proteins like PICK1 and Rab2 to ensure that hormones and receptors are properly packaged for secretion. The current understanding, supported by cross-species studies and gene knockout models, is that ICA1 is a **conserved regulator of neuroendocrine secretion** ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Islet,are%20conserved%20regulators%20of%20neuroendocrine)), indispensable for processes ranging from insulin granule maturation in pancreatic β-cells to neurotransmitter receptor trafficking in neurons. Recent research (2023–2024) has expanded the significance of ICA1, connecting it to higher-order physiological outcomes: synaptic plasticity and memory formation are impaired without ICA1 ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory)), and even pathways relevant to Alzheimer’s disease may be modulated by ICA1 via PICK1–PKCα interactions ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD)). These developments underscore the gene’s broad impact. ICA1’s **primary function** is structural – it does not catalyze reactions or transport ions, but it provides a physical platform that shapes vesicles and positions key molecules where they are needed in the cell. Its **subcellular localization** to the cytosolic face of Golgi and secretory vesicle membranes is absolutely integral to this role, as it operates at the nexus of vesicle budding and cargo sorting ([www.wikidoc.org](https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1)) ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water)). In terms of pathways, ICA1 is entwined with the **secretory pathway** (ER-to-Golgi transport, granule biogenesis) and with intracellular signaling cascades indirectly (through effects on PKC and possibly other kinases). 

From a biomedical perspective, ICA1 illustrates how a protein can be simultaneously a basic cellular workhorse and a factor in disease contexts. As an autoantigen, it provided early clues into T1D pathogenesis, and as a trafficking protein, it continues to reveal new biology in metabolism and brain function. Ongoing studies are likely to further clarify how ICA1’s interactions (with Rab GTPases, BAR domain partners, and PDZ domain proteins) are regulated and how they might be leveraged to treat diseases of secretion or protein misprocessing. In summary, **ICA1/ICA69 is now recognized as a pivotal component of the cellular machinery for secretory vesicle formation and a guardian of proper cargo delivery**, with impacts that resonate from endocrine hormone release to synaptic receptor distribution. This comprehensive understanding is built on a foundation of precise experimental evidence, ranging from biochemical binding assays and imaging of granules ([www.bioch.ox.ac.uk](https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in)) ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water)) to whole-animal physiology tests (glucose tolerance, behavioral assays) in ICA1 mutant mice ([journals.plos.org](https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory)), all converging on the idea that ICA1 is essential for the fidelity of the secretory system in human cells. 



## Citations

1. AnnotationURLCitation(end_index=300, start_index=210, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69')
2. AnnotationURLCitation(end_index=511, start_index=415, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200')
3. AnnotationURLCitation(end_index=782, start_index=648, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and')
4. AnnotationURLCitation(end_index=1062, start_index=957, title='ICA1 - wikidoc', type='url_citation', url='https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1')
5. AnnotationURLCitation(end_index=1276, start_index=1149, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L528%20Ica1%2C%20is,ICA69%20is')
6. AnnotationURLCitation(end_index=2115, start_index=2025, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69')
7. AnnotationURLCitation(end_index=2522, start_index=2330, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or')
8. AnnotationURLCitation(end_index=2716, start_index=2620, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200')
9. AnnotationURLCitation(end_index=3126, start_index=3021, title='ICA1 - wikidoc', type='url_citation', url='https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1')
10. AnnotationURLCitation(end_index=3314, start_index=3218, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200')
11. AnnotationURLCitation(end_index=3640, start_index=3455, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
12. AnnotationURLCitation(end_index=3731, start_index=3641, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=ICA69')
13. AnnotationURLCitation(end_index=4316, start_index=4182, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and')
14. AnnotationURLCitation(end_index=4848, start_index=4721, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L528%20Ica1%2C%20is,ICA69%20is')
15. AnnotationURLCitation(end_index=5163, start_index=5023, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Islet,are%20conserved%20regulators%20of%20neuroendocrine')
16. AnnotationURLCitation(end_index=5749, start_index=5564, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
17. AnnotationURLCitation(end_index=6057, start_index=5866, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=different%20stages%20of%20their%20maturation,to%20increased%20food%20and%20water')
18. AnnotationURLCitation(end_index=7087, start_index=6953, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=Islet%20cell%20autoantigen%20of%2069,ICA512%20and')
19. AnnotationURLCitation(end_index=7246, start_index=7088, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
20. AnnotationURLCitation(end_index=7618, start_index=7460, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
21. AnnotationURLCitation(end_index=8163, start_index=8005, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
22. AnnotationURLCitation(end_index=8834, start_index=8633, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
23. AnnotationURLCitation(end_index=9613, start_index=9428, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
24. AnnotationURLCitation(end_index=10099, start_index=9914, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
25. AnnotationURLCitation(end_index=10301, start_index=10100, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
26. AnnotationURLCitation(end_index=10829, start_index=10638, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=different%20stages%20of%20their%20maturation,to%20increased%20food%20and%20water')
27. AnnotationURLCitation(end_index=11349, start_index=11148, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
28. AnnotationURLCitation(end_index=11676, start_index=11475, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
29. AnnotationURLCitation(end_index=12192, start_index=11991, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
30. AnnotationURLCitation(end_index=12454, start_index=12297, title='PICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose tolerance - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=in%20mice%20caused%20the%20complete,and%20maturation%20of%20insulin%20granules')
31. AnnotationURLCitation(end_index=12955, start_index=12855, title='PICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose tolerance - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=Comment%20in%20,PICK1')
32. AnnotationURLCitation(end_index=13412, start_index=13220, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or')
33. AnnotationURLCitation(end_index=13756, start_index=13564, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=the%20biogenesis%20and%20maturation%20of,Mice%20lacking%20functional%20PICK1%20or')
34. AnnotationURLCitation(end_index=14348, start_index=14174, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR')
35. AnnotationURLCitation(end_index=14824, start_index=14682, title='TBC-8, a putative RAB-2 GAP, regulates dense core vesicle maturation in Caenorhabditis elegans - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/22654674/#:~:text=Caenorhabditis%20elegans%20,specific%20cargo%20is%20lost%20from')
36. AnnotationURLCitation(end_index=15106, start_index=14964, title='TBC-8, a putative RAB-2 GAP, regulates dense core vesicle maturation in Caenorhabditis elegans - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/22654674/#:~:text=Caenorhabditis%20elegans%20,specific%20cargo%20is%20lost%20from')
37. AnnotationURLCitation(end_index=16531, start_index=16366, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=in%20the%20biogenesis%20of%20secretory,and%20morphological%20analysis%20of%20CA1')
38. AnnotationURLCitation(end_index=17000, start_index=16835, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=in%20the%20biogenesis%20of%20secretory,and%20morphological%20analysis%20of%20CA1')
39. AnnotationURLCitation(end_index=17300, start_index=17127, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
40. AnnotationURLCitation(end_index=17628, start_index=17510, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=levels,dependent%20learning%20and')
41. AnnotationURLCitation(end_index=18120, start_index=17947, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
42. AnnotationURLCitation(end_index=18421, start_index=18248, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
43. AnnotationURLCitation(end_index=18712, start_index=18539, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
44. AnnotationURLCitation(end_index=19122, start_index=18949, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
45. AnnotationURLCitation(end_index=19619, start_index=19452, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic')
46. AnnotationURLCitation(end_index=19902, start_index=19735, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic')
47. AnnotationURLCitation(end_index=20253, start_index=20096, title='PICK1 and ICA69 control insulin granule trafficking and their deficiencies lead to impaired glucose tolerance - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23630453/#:~:text=in%20mice%20caused%20the%20complete,and%20maturation%20of%20insulin%20granules')
48. AnnotationURLCitation(end_index=20421, start_index=20254, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=the%20AMPAR%20protein%20complex%20through,ICA69%20does%20not%20regulate%20synaptic')
49. AnnotationURLCitation(end_index=20883, start_index=20760, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=Long,to%20the%20cell%20surface%2C%20or')
50. AnnotationURLCitation(end_index=21060, start_index=20884, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=trafficking%20pathways%20regulate%20the%20surface,plasticity%20and%20animal%20behavior%20by')
51. AnnotationURLCitation(end_index=21405, start_index=21224, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=synapse%20trapping%20and%20subsequent%20endocytosis%2C,plasticity%20and%20animal%20behavior%20by')
52. AnnotationURLCitation(end_index=21975, start_index=21847, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=19,View%20Article')
53. AnnotationURLCitation(end_index=23570, start_index=23412, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
54. AnnotationURLCitation(end_index=24217, start_index=24121, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=,M213222200')
55. AnnotationURLCitation(end_index=25133, start_index=24985, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Islet%20cell%20autoantigen%201%20,and%20an%20AD%20mouse%20model')
56. AnnotationURLCitation(end_index=25293, start_index=25134, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD')
57. AnnotationURLCitation(end_index=25533, start_index=25438, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Conclusion')
58. AnnotationURLCitation(end_index=25861, start_index=25682, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
59. AnnotationURLCitation(end_index=26203, start_index=26024, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
60. AnnotationURLCitation(end_index=26545, start_index=26402, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=17%20,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
61. AnnotationURLCitation(end_index=27350, start_index=27191, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD')
62. AnnotationURLCitation(end_index=29001, start_index=28827, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR')
63. AnnotationURLCitation(end_index=29373, start_index=29172, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
64. AnnotationURLCitation(end_index=29548, start_index=29374, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=biogenesis%20of%20insulin%20secretory%20vesicles,major%20scaffold%20protein%20for%20AMPAR')
65. AnnotationURLCitation(end_index=30200, start_index=30063, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells')
66. AnnotationURLCitation(end_index=30437, start_index=30300, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells')
67. AnnotationURLCitation(end_index=30770, start_index=30647, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=Anti,T1D%20and%20SPIDDM%20cases%20were')
68. AnnotationURLCitation(end_index=30873, start_index=30771, title='Anti-Islet Autoantibodies in Type 1 Diabetes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10298549/#:~:text=diabetes%20,islet')
69. AnnotationURLCitation(end_index=31290, start_index=31185, title='ICA1 - wikidoc', type='url_citation', url='https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1')
70. AnnotationURLCitation(end_index=31432, start_index=31291, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Seminal%20studies%20by%20Atkinson%20et,cell%20injury%20in')
71. AnnotationURLCitation(end_index=31968, start_index=31822, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=in%20the%20neuroendocrine%20system,In%20this%20context%2C%20we')
72. AnnotationURLCitation(end_index=32137, start_index=31969, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=autoantigens%20play%20diverse%20roles%20in,GAD65%2C%20ZnT8%2C%20IA2%2C%20and%20ICA69')
73. AnnotationURLCitation(end_index=32595, start_index=32424, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L539%20autoreactive%20to,expression%20in%20medullary%20thymic%20epithelial')
74. AnnotationURLCitation(end_index=32878, start_index=32703, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=match%20at%20L134%20while%20ICA69,accelerated%20diabetes%20%5B25')
75. AnnotationURLCitation(end_index=33735, start_index=33598, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=match%20at%20L535%20ICA69%20can,Second%2C%20T%20cells')
76. AnnotationURLCitation(end_index=33906, start_index=33736, title='Compromised central tolerance of ICA69 induces multiple organ autoimmunity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4704797/#:~:text=For%20reasons%20not%20fully%20understood%2C,%CE%94ICA69%20line.%20Suboptimal%20central')
77. AnnotationURLCitation(end_index=34242, start_index=34072, title='Compromised central tolerance of ICA69 induces multiple organ autoimmunity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4704797/#:~:text=For%20reasons%20not%20fully%20understood%2C,%CE%94ICA69%20line.%20Suboptimal%20central')
78. AnnotationURLCitation(end_index=34711, start_index=34563, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Islet%20cell%20autoantigen%201%20,and%20an%20AD%20mouse%20model')
79. AnnotationURLCitation(end_index=35107, start_index=34928, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=The%20ICA1%20increased%20the%20expression,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
80. AnnotationURLCitation(end_index=35393, start_index=35250, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=17%20,PKC%CE%B1%20protein%20levels%20and%20phosphorylation')
81. AnnotationURLCitation(end_index=36152, start_index=35993, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD')
82. AnnotationURLCitation(end_index=36689, start_index=36516, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
83. AnnotationURLCitation(end_index=37874, start_index=37748, title='ICA1 Gene - GeneCards | ICA69 Protein | ICA69 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=ICA1#:~:text=GeneCards%20Summary%20for%20ICA1%20Gene')
84. AnnotationURLCitation(end_index=38643, start_index=38503, title='Islet Autoantigens: Structure, Function, Localization, and Regulation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3405822/#:~:text=Islet,are%20conserved%20regulators%20of%20neuroendocrine')
85. AnnotationURLCitation(end_index=39149, start_index=38976, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')
86. AnnotationURLCitation(end_index=39413, start_index=39254, title='ICA1 affects APP processing through the PICK1‐PKCα signaling pathway - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11181291/#:~:text=Our%20results%20demonstrated%20that%20ICA1,for%20the%20treatment%20of%20AD')
87. AnnotationURLCitation(end_index=39987, start_index=39882, title='ICA1 - wikidoc', type='url_citation', url='https://www.wikidoc.org/index.php/ICA1#:~:text=This%20gene%20encodes%20a%20protein,1')
88. AnnotationURLCitation(end_index=40173, start_index=39988, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
89. AnnotationURLCitation(end_index=41519, start_index=41361, title='ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells | Biochemistry', type='url_citation', url='https://www.bioch.ox.ac.uk/publication/310269/scopus#:~:text=small%20GTPase%20Rab2%2C%20which%20regulates,point%20to%20its%20role%20in')
90. AnnotationURLCitation(end_index=41705, start_index=41520, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=report%20that%20PICK1%20and%20ICA69%2C,to%20increased%20food%20and%20water')
91. AnnotationURLCitation(end_index=41999, start_index=41798, title='PICK1 and ICA69 Control Insulin Granule Trafficking and Their Deficiencies Lead to Impaired Glucose Tolerance | PLOS Biology', type='url_citation', url='https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1001541#:~:text=secretory%20granules%20were%20associated%20with,and%20maturation%20of%20insulin%20granules')
92. AnnotationURLCitation(end_index=42173, start_index=42000, title='ICA69 regulates activity-dependent synaptic strengthening and learning and memory - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10213502/#:~:text=and%20dendrite%20architecture%2C%20indicating%20that,dependent%20learning%20and%20memory')